Levi & Korsinsky alleges in the complaint that the losses in ARE’s stock were caused by the Company’s alleged misrepresentations about its LIC property. In particular, the complaint states that the Company did not have “reliable information pertaining to the Company’s leasing spreads, development tenant pipeline, and anticipated occupancy growth for its life-science properties, specifically its LIC property while also minimizing risk from macroeconomic fluctuations.” Levi & Korsinsky further argues that “the Company’s LIC value and potential growth as a life-science destination had been declining for years,” consequently making the Company’s optimistic reports about its “development pipeline, high occupancy rates in North America and anticipated leasing growth” materially misleading.